PHARMANUTRA SpA

Discover PHARMANUTRA SpA: excellence in nutraceuticals and medical devices

PHARMANUTRA SpA is an Italian company founded in 2003 in Pisa by brothers Andrea and Roberto Lacorte, specializing in the development of innovative dietary supplements and medical devices. With over 20 years of experience, the company stands out for its use of the Sucrosomal Technology®, a patented system that enhances the absorption of minerals and vitamins, reducing gastrointestinal side effects.

Innovation and research in the service of well-being

PHARMANUTRA SpA continually invests in research and development, with a biomolecular research center among the most advanced in Europe. This commitment has led to the creation of exclusive patents, such as the Sucrosomal Technology® and the functional principle of Cethyl Esters, used in products like SiderAL® and Cetilar®, respectively for treating iron deficiencies and supporting joint and muscle mobility.

Product range and recognitions

Among PHARMANUTRA SpA's flagship products are:

• SiderAL®: a line of supplements based on Sucrosomal Iron®, indicated to counteract iron deficiencies.
• Cetilar®: a range of topical and oral products based on Cethyl Esters, useful for the treatment of muscle and joint pain.
• Apportal®: a complete multivitamin supplement designed to support energy and overall well-being.
• UltraMag®: a Sucrosomal Magnesium® supplement, useful for reducing tiredness and fatigue.

In 2025, SiderAL® Forte was awarded as "Best nutraceutical product" during the Nutritional Space event, recognizing the effectiveness and innovation of its products.